N
ACHV icon

Nuveen’s Achieve Life Sciences ACHV Stock Holding History

Nuveen’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-46,668
Closed -$125K – 3275
2025
Q1 		$125K Hold
46,668
– – ﹤0.01% 3197
2024
Q4 		$164K Hold
46,668
– – ﹤0.01% 3234
2024
Q3 		$221K Hold
46,668
– – ﹤0.01% 3208
2024
Q2 		$219K Buy
+46,668
New +$225K ﹤0.01% 3198

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen's ACHV Position: Q2 2025 in Review

Nuveen sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 46,668 shares — an estimated $125K sold.

Nuveen first reported a position in ACHV in Q2 2024 and held it in 4 quarters. The position peaked at $221K in Q3 2024. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • Nuveen reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 46,668 Achieve Life Sciences shares in Q2 2025, an estimated $125K.
  • Nuveen first reported a position in Achieve Life Sciences in Q2 2024 and held it in 4 quarters.
  • Nuveen's Achieve Life Sciences position peaked at $221K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.